Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease

Part of paid clinical trials in La Jolla, California.

Sponsor
Abbott
Study ID
NCT00077779
Phase
PHASE3
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this study is to test whether Adalimumab (at two different doses) can induce and maintain clinical remission in subjects with active Crohn's disease when compared to placebo (a substance containing no medication)

Key Dates

Start date
Jul 31, 2003
Status verified
Sep 2007

Study Design

Enrollment
854 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Primary Outcome Measure

Clinical remission (CDAI<150). [ Time Frame: 56 weeks ]

Locations (43)

FacilityCityStateZIPSite coordinators
Thornton Hospital Reumatology DivisionLa JollaCalifornia92037-0943-
Cal-West, Inc.San FranciscoCalifornia94117-
UCSF San Francisco General HospitalSan FranciscoCalifornia94110-
Western States Clinical ResearchArvadaColorado80002-
Gastroenterology Associates of Fairfield CountyBridgeportConnecticut06606-
Clinical Research of West Florida, Inc.ClearwaterFlorida33765-
V.A. Medical CenterGainsvilleFlorida32608-
Mark Lamet, MDHollywoodFlorida33021-
Gastroenterology ConsultantsOrmond BeachFlorida32174-
Northwest GastroenterologyArlington HeightsIllinois60005-
Northwestern UniversityChicagoIllinois60611-
The University of ChicagoChicagoIllinois60637-
Indianapolis Gastroenterology Research FoundationIndianapolisIndiana46237-
St. Vincent Hospital: Research DepartmentIndianapolisIndiana46260-
Drug Research Services, Inc.MetairieLouisiana70001-
Maryland Clinical TrialsAnnapolisMaryland21401-
Chevy Chase Clinical ResearchChevy ChaseMaryland20815-
Capital Gastroenterology Consultants, P.A.Silver SpringMaryland20901-
Clinical Pharmacology Study GroupWorcesterMassachusetts01610-
Mayo Clinic ResearchRochesterMinnesota55905-0002-
Gastroenterology & HematologyKansas CityMissouri64131-
Glenn Gordon, MDMexicoMissouri65265-
Washington University SchoolSt LouisMissouri63110-
Washington University School of MedicineSt LouisMissouri63110-
Long Island Clinical Research Assoc.Great NeckNew York11021-
NY Center for Clinical ResearchLake SuccessNew York11042-
Daniel Present, MDNew YorkNew York10029-
Digestive Disease Associates of RocklandPomonaNew York10970-
Carolina Digestive Health AssociatesCharlotteNorth Carolina28211-
Carolina Research AssociatesCharlotteNorth Carolina28262-
Charlotte Gastroenterology & HepatologyCharlotteNorth Carolina28207-
Le Bauer Research, P.A.GreensboroNorth Carolina27403-
Wilmington GastroenterologyWilmingtonNorth Carolina28401-
University Hospitals of ClevelandClevelandOhio44106-
Westhills GastroenterologyPortlandOregon98112-
Altoona Center for Clinical ResearchDuncansvillePennsylvania16635-
University of Pittsburgh Medical CenterPittsburghPennsylvania15261-
Columbia Gastro AssociatesColumbiaSouth Carolina29204-
Gastroenterology Center of the Mid SouthMemphisTennessee38120-
Nashville Medical ResearchNashvilleTennessee37205-
Gastrointestinal SpecialistsRichmondVirginia23230-
Discovery Research Inteternational, LLCMilwaukeeWisconsin53215-
Wisconsin Center for Advanced ResearchMilwaukeeWisconsin53215-

Find similar trials in La Jolla, CA

By condition
Crohn's disease
By specialty
GastroenterologyInflammatory bowel diseaseAutoimmune disease
By research site
Thornton Hospital Reumatology Division· La Jolla, CACal-West, Inc.· San Francisco, CAUCSF San Francisco General Hospital· San Francisco, CAWestern States Clinical Research· Arvada, COGastroenterology Associates of Fairfield County· Bridgeport, CTClinical Research of West Florida, Inc.· Clearwater, FL

Related Studies